233 related articles for article (PubMed ID: 8473043)
1. Conditional expression and oncogenicity of c-myc linked to a CD2 gene dominant control region.
Stewart M; Cameron E; Campbell M; McFarlane R; Toth S; Lang K; Onions D; Neil JC
Int J Cancer; 1993 Apr; 53(6):1023-30. PubMed ID: 8473043
[TBL] [Abstract][Full Text] [Related]
2. Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral tagging.
Blyth K; Terry A; Mackay N; Vaillant F; Bell M; Cameron ER; Neil JC; Stewart M
Oncogene; 2001 Jan; 20(3):295-302. PubMed ID: 11313958
[TBL] [Abstract][Full Text] [Related]
3. Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss.
Blyth K; Terry A; O'Hara M; Baxter EW; Campbell M; Stewart M; Donehower LA; Onions DE; Neil JC; Cameron ER
Oncogene; 1995 May; 10(9):1717-23. PubMed ID: 7753548
[TBL] [Abstract][Full Text] [Related]
4. til-1: a novel proviral insertion locus for Moloney murine leukaemia virus in lymphomas of CD2-myc transgenic mice.
Stewart M; Terry A; O'Hara M; Cameron E; Onions D; Neil JC
J Gen Virol; 1996 Mar; 77 ( Pt 3)():443-6. PubMed ID: 8601779
[TBL] [Abstract][Full Text] [Related]
5. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.
Baxter EW; Blyth K; Cameron ER; Neil JC
J Virol; 2001 Oct; 75(20):9790-8. PubMed ID: 11559812
[TBL] [Abstract][Full Text] [Related]
6. The common retroviral insertion locus Dsi1 maps 30 kilobases upstream of the P1 promoter of the murine Runx3/Cbfa3/Aml2 gene.
Stewart M; MacKay N; Cameron ER; Neil JC
J Virol; 2002 May; 76(9):4364-9. PubMed ID: 11932403
[TBL] [Abstract][Full Text] [Related]
7. MoMuLV proviral integrations identified by Sup-F selection in tumors from infected myc/pim bitransgenic mice correlate with activation of the gfi-1 gene.
Schmidt T; Zörnig M; Beneke R; Möröy T
Nucleic Acids Res; 1996 Jul; 24(13):2528-34. PubMed ID: 8692692
[TBL] [Abstract][Full Text] [Related]
8. Cooperation of Myb and Myc proteins in T cell lymphomagenesis.
Davies J; Badiani P; Weston K
Oncogene; 1999 Jun; 18(24):3643-7. PubMed ID: 10380886
[TBL] [Abstract][Full Text] [Related]
9. Genetic determinants of feline leukemia virus-induced lymphoid tumors: patterns of proviral insertion and gene rearrangement.
Tsatsanis C; Fulton R; Nishigaki K; Tsujimoto H; Levy L; Terry A; Spandidos D; Onions D; Neil JC
J Virol; 1994 Dec; 68(12):8296-303. PubMed ID: 7966623
[TBL] [Abstract][Full Text] [Related]
10. Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis.
Schmidt T; Karsunky H; Gau E; Zevnik B; Elsässer HP; Möröy T
Oncogene; 1998 Nov; 17(20):2661-7. PubMed ID: 9840930
[TBL] [Abstract][Full Text] [Related]
11. Apparent bypass of negative selection in CD8+ tumours in CD2-myc transgenic mice.
Cameron ER; Campbell M; Blyth K; Argyle SA; Keanie L; Neil JC; Onions DE
Br J Cancer; 1996 Jan; 73(1):13-7. PubMed ID: 8554976
[TBL] [Abstract][Full Text] [Related]
12. Retroviral infection accelerates T lymphomagenesis in E mu-N-ras transgenic mice by activating c-myc or N-myc.
Haupt Y; Harris AW; Adams JM
Oncogene; 1992 May; 7(5):981-6. PubMed ID: 1570158
[TBL] [Abstract][Full Text] [Related]
13. Loss of Fas/Apo-1 receptor accelerates lymphomagenesis in E mu L-MYC transgenic mice but not in animals infected with MoMuLV.
Zörnig M; Grzeschiczek A; Kowalski MB; Hartmann KU; Möröy T
Oncogene; 1995 Jun; 10(12):2397-401. PubMed ID: 7784089
[TBL] [Abstract][Full Text] [Related]
14. Moloney virus induction of T-cell lymphomas in a plasmacytomagenic strain of E mu-v-abl transgenic mice.
Haupt Y; Harris AW; Adams JM
Int J Cancer; 1993 Oct; 55(4):623-9. PubMed ID: 8406991
[TBL] [Abstract][Full Text] [Related]
15. The programmed cell death of an immature thymocyte cell line transgenic for an alpha beta TCR and the c-myc proto-oncogene.
Murdjeva M; Tanaka Y; Norton T; Kioussis D
Dev Immunol; 1996; 4(4):279-88. PubMed ID: 8924763
[TBL] [Abstract][Full Text] [Related]
16. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
[TBL] [Abstract][Full Text] [Related]
17. Moloney murine leukemia virus-induced lymphomas in p53-deficient mice: overlapping pathways in tumor development?
Baxter EW; Blyth K; Donehower LA; Cameron ER; Onions DE; Neil JC
J Virol; 1996 Apr; 70(4):2095-100. PubMed ID: 8642629
[TBL] [Abstract][Full Text] [Related]
18. Characterization of lymphoid tumors induced by a recombinant murine retrovirus carrying the avian v-myc oncogene. Identification of novel (B-lymphoid) tumors in the thymus.
Brightman BK; Chandy KG; Spencer RH; Gupta S; Pattengale PK; Fan H
J Immunol; 1988 Oct; 141(8):2844-54. PubMed ID: 2902139
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic potential of cyclin E in T-cell lymphomagenesis in transgenic mice: evidence for cooperation between cyclin E and Ras but not Myc.
Karsunky H; Geisen C; Schmidt T; Haas K; Zevnik B; Gau E; Möröy T
Oncogene; 1999 Dec; 18(54):7816-24. PubMed ID: 10618723
[TBL] [Abstract][Full Text] [Related]
20. A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with myc.
Vaillant F; Blyth K; Terry A; Bell M; Cameron ER; Neil J; Stewart M
Oncogene; 1999 Nov; 18(50):7124-34. PubMed ID: 10597314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]